Latest: FDA Approves New Biosimilar for Oncology Treatment

STAT+: Pharmalittle: We’re reading about FDA reporting side effects, pharma plants near disaster zones, and more

0 Mins
The FDA has begun publishing reports of adverse events concerning drugs and biological products on a daily basis
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago